Advertisement

Effects of Cholesterol-Depleting Agent Methyl-β-Cyclodextrin on the Functional State of Brain Nerve Terminals

  • Tatiana Borisova
Chapter
Part of the SpringerBriefs in Neuroscience book series (BRIEFSNEUROSCI, volume 12)

Abstract

Cholesterol acceptor methyl-β-cyclodextrin (MβCD) (15 mM) reduced the cholesterol content in brain nerve terminals (synaptosomes) by one quarter. The application of MβCD to the synaptosomes as well as isolated synaptic vesicles led to the gradual leakage of the protons from the vesicles, as shown by acridine orange fluorescence measurements, whereas the application of MβCD complexed with cholesterol (15:0.2) that increased the membrane cholesterol content stimulated additional vesicle acidification. It was supposed that cholesterol depletion of the plasma membrane with MβCD induced the removal of cholesterol from the membranes of synaptic vesicles resulting in immediate dissipation of synaptic vesicle proton gradient, and so could provoke redistribution of the neurotransmitter between the vesicular and cytosolic pools.

Keywords

Synaptic Vesicle Acridine Orange Proton Gradient Vesicle Acidification Cholesterol Depletion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Borisova T, Krisanova N, Sivko R, Borysov A (2010a) Cholesterol depletion attenuates tonic release but increases the ambient level of glutamate in rat brain synaptosomes. Neurochem Int 56:466–478CrossRefGoogle Scholar
  2. Borisova T, Sivko R, Borysov A, Krisanova N (2010b) Diverse presynaptic mechanisms underlying methyl-beta-cyclodextrin—mediated changes in glutamate transport. Cell Mol Neurobiol 30:1013–1023CrossRefGoogle Scholar
  3. Borisova T, Kasatkina L, Ostapchenko L (2011) The proton gradient of secretory granules and glutamate transport in blood platelets during cholesterol depletion of the plasma membrane by methyl-beta-cyclodextrin. Neurochem Int 59:965–975PubMedCrossRefGoogle Scholar
  4. Cotman CW (1974) Isolation of synaptosomal and synaptic plasma membrane fractions. Methods Enzymol 31:445–452PubMedCrossRefGoogle Scholar
  5. Gylys K, Fein J, Cole GM (2000) Quantitative characterization of crude synaptosomal fraction (P-2) components by flow cytometry. J Neurosci Res 61:186–192PubMedCrossRefGoogle Scholar
  6. Krisanova NV, Ttiksh IO, Borisova TA (2009) Synaptopathy under conditions of altered gravity: changes in synaptic vesicle fusion and glutamate release. Neurochem Int 55:724–731PubMedCrossRefGoogle Scholar
  7. Krisanova N, Sivko R, Kasatkina L, Borisova T (2012) Neuroprotection by lowering cholesterol: a decrease in membrane cholesterol content reduces transporter-mediated glutamate release from brain nerve terminals. Biochim Biophys Acta 1822:1013–1023Google Scholar
  8. Kruth HS, Vaughan M (1980) Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy. J Lipid Res 21:123–130PubMedGoogle Scholar
  9. Lange Y, Ye J, Rigney M, Steck TL (1999) Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res 40:2264–2269PubMedGoogle Scholar
  10. Larson E, Howlett B, Jagendorf A (1986) Artificial reductant enhancement of the Lowry method for protein determination. Anal Biochem 155:243–248PubMedCrossRefGoogle Scholar
  11. Mullaney PF, Van Dilla MA, Coulter JR (1969) Cell sizing: a light scattering photometer for rapid volume determination. Rev Sci Instrum 40:1029–1032PubMedCrossRefGoogle Scholar
  12. Perez-Castiñeira JR, Apps DK (1990) Vacuolar H(+)-ATPase of adrenal secretory granules. Rapid partial purification and reconstitution into proteoliposomes. Biochem J 271:127–131PubMedPubMedCentralGoogle Scholar
  13. Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27:509–547PubMedCrossRefGoogle Scholar
  14. Tarasenko AS, Sivko RV, Krisanova NV, Himmelreich NH, Borisova TA (2010) Cholesterol depletion from the plasma membrane impairs proton and glutamate storage in synaptic vesicles of nerve terminals. J Mol Neurosci 41:358–367PubMedCrossRefGoogle Scholar
  15. Wasser CR, Ertunc M, Liu X et al (2007) Cholesterol-dependent balance between evoked and spontaneous vesicle recycling. J Physiol 579(2):413–429PubMedCrossRefPubMedCentralGoogle Scholar
  16. Wolf M, Kapatos G (1989) Flow cytometric analysis of rat striatal nerve terminals. J Neurosci 9:94–105PubMedGoogle Scholar
  17. Zamir O, Charlton MP (2006) Cholesterol and synaptic transmitter release at crayfish neuromuscular junctions. J Physiol 571:83–99PubMedCrossRefPubMedCentralGoogle Scholar
  18. Zidovetzki R, Levitan I (2007) Use of cyclodextrins to manipulatre plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768:1311–1324PubMedCrossRefPubMedCentralGoogle Scholar
  19. Zoccarato F, Cavallini L, Alexandre A (1999) The pH-sensitive dye acridine orange as a tool to monitor exocytosis/endocytosis in synaptosomes. J Neurochem 72:625–633PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Tatiana Borisova
    • 1
  1. 1.Department of Neurochemistry Palladin Institute of BiochemistryNational Academy of Sciences of UkraineKievUkraine

Personalised recommendations